⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine EU May 8, 2025

NovoRapid PumpCart (insulin aspart)

📷 PubChem CID 16132418 · Source
NovoRapid PumpCart (insulin aspart)
📷 PubChem CID 16132418 · Source
INN
insulin aspart
Forms
Solution for injection in a cartridge
Strengths
100 units/mL
Alternatives
Yes
⚠️
Shortage ongoing
insulin aspart is currently in short supply in EU.
📈 Timeline
73 days active so far
May 16, 2026 July 27, 2026

What is this? NovoRapid PumpCart is a medicine that contains insulin aspart. It is used to control blood sugar in people with diabetes.

What's happening? There is a shortage of NovoRapid PumpCart in the EU. This means some people may not be able to get it right now.

Does this affect me? If you use NovoRapid PumpCart, this shortage may affect you. Check with your pharmacist.

What should I do? Talk to your doctor or pharmacist about other insulin options that may work for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
insulin aspart
Brand(s) / product name(s)
NovoRapid PumpCart (insulin aspart)
Agency-published detail

INN: insulin aspart · Forms: Solution for injection in a cartridge · Strengths: 100 units/mL · Alternatives: Yes

First published
May 8, 2025
Last refreshed by us
14 hours ago
Severity (as classified)
High
Official source
https://www.ema.europa.eu/en/medicines/human/shortages/novorapid-pumpcart-insulin-aspart

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
NovoRapid PumpCart (insulin aspart). INN: insulin aspart · Forms: Solution for injection in a cartridge · Strengths: 100 units/mL · Alternatives: Yes
▸ When was this alert issued?
This alert was issued on May 8, 2025 by EMA (European Medicines Agency).
▸ Which countries are affected?
The alert applies to the entire EU.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.